Simulations Plus

Simulations Plus Treasury Stock

Delisted·Oct 7, 2026

The Treasury Stock of Simulations Plus (SLP) as of Nov 11, 2026 is 159.42 M USD. In the previous year, Treasury Stock was 152.31 M USD — a change of 4.67% (higher).

Treasury Stock

159.42 MUSD

YoY

4.67%

Last updated:

Treasury Stock of Simulations Plus is 2025 159.42 M USD. Treasury Stock of Simulations Plus was 2024 152.31 M USD. It decreases by 4.67% higher compared to the previous year.

The Simulations Plus Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2018
13.45 M USD
Jan 1, 2019
15.32 M USD
Jan 1, 2020
128.53 M USD
Jan 1, 2021
133.42 M USD
Jan 1, 2022
-308,000.00 USD
Jan 1, 2023
-1.00 USD
Jan 1, 2024
152.31 M USD
Jan 1, 2025
159.42 M USD
The Simulations Plus Treasury Stock history
YEARTreasury StockYoY
159.42 MUSD+4.67%
152.31 MUSD-15.23 B%
-1.00USD-100.00%
-308,000.00USD-100.23%
133.42 MUSD+3.80%
128.53 MUSD+739.01%
15.32 MUSD+13.87%
13.45 MUSD+11.10%
12.11 MUSD+6.44%
11.38 MUSD+17.11%
9.71 MUSD+59.63%
6.09 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Treasury Stock of Simulations Plus is 159.42 M USD in 2025.

Treasury Stock of Simulations Plus changed from 152.31 M USD to 159.42 M USD, representing a 4.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus